- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 453/02 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Patent holdings for IPC class C07D 453/02
Total number of patents in this class: 630
10-year publication summary
|
41
|
60
|
49
|
50
|
31
|
27
|
38
|
27
|
15
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chiesi Farmaceutici S.p.A. | 959 |
37 |
| Genzyme Corporation | 1342 |
16 |
| Corsair Pharma, Inc. | 37 |
14 |
| Renexxion, LLC | 15 |
13 |
| Glaxo Group Limited | 4364 |
11 |
| Astellas Pharma Inc. | 1036 |
11 |
| Novartis AG | 10341 |
10 |
| Bristol-myers Squibb Company | 4815 |
10 |
| Vertex Pharmaceuticals Incorporated | 1595 |
10 |
| Beijing Showby Pharmaceutical Co., Ltd. | 15 |
9 |
| AstraZeneca AB | 2828 |
8 |
| Merck Patent GmbH | 5669 |
8 |
| Array BioPharma Inc. | 458 |
8 |
| Obschestvo S Ogranichennoi Otvetstvennostiyu "pharmenterprises" | 30 |
8 |
| SK Biopharmaceuticals Co., Ltd. | 273 |
8 |
| XENIOPRO GmbH | 16 |
8 |
| Boehringer Ingelheim International GmbH | 4496 |
7 |
| Almirall, S.A. | 489 |
7 |
| Hovione Scientia Limited | 131 |
7 |
| Takeda Pharmaceutical Company Limited | 2716 |
6 |
| Other owners | 414 |